Company Encyclopedia
View More
name
AdvisorShares Pure Cannabis ETF
YOLO.US
News
View More

Shareholder Cannell Capital LLC Files To Sell 16,100 Of SNDL Inc [SNDL]

Cannell Capital LLC, a shareholder of SNDL Inc, filed a Form 144 with the SEC to sell 16,100 restricted shares of SNDL Inc on December 12, 2025. The sale will be conducted through Schwab & Co Inc. Filing Form 144 is a prerequisite for selling restricted stock, allowing the sale within 90 days of filing.

Reuters·
US
SNDL
+24.86%
Reuters·
US
SNDL
+24.86%

Tilray's stock takes off on hope that cannabis will soon be seen as more like steroids than heroin

Tilray's stock surged 44.1% as reports suggested President Trump might reclassify marijuana as a Schedule III drug, easing banking restrictions and potentially leading to further legalization. This reclassification could allow larger banks to engage with cannabis businesses, boosting the industry. Other cannabis stocks, like Canopy Growth and Cronos Group, also saw significant gains. However, the White House has not confirmed any decision, and past investor optimism has sometimes been premature.

Dow Jones·
US
CGC
+53.98%
US
CRON
+14.74%
US
TLRY
+44.13%
Dow Jones·
US
CGC
+53.98%
US
CRON
+14.74%
US
TLRY
+44.13%

Top 10 US Stock Gainers (12.12)

Canopy Growth(CGC) rose 53.98%, with a trading turnover 249.9 Million USD, and a year-to-date fell 36.5%. Tilray Brands(TLRY) rose 44.13%, with a trading turnover 914.6 Million USD, and a year-to-date fell 8.6%. Cronos(CRON) rose 14.74%, with a trading turnover 53.6 Million USD, and a year-to-date rose 61.9%.

Top Gainers & Losers·
US
CGC
+53.98%
US
TLRY
+44.13%
US
CRON
+14.74%
Top Gainers & Losers·
US
CGC
+53.98%
US
TLRY
+44.13%
US
CRON
+14.74%

Stock Traders Buy High Volume of Tilray Brands Call Options (NASDAQ:TLRY)

Tilray Brands (NASDAQ:TLRY) experienced a significant increase in call options trading, with 167,580 options purchased, up 58% from the average volume. The stock price rose to $12.15, with a market cap of $1.36 billion. Analysts have mixed ratings, with a consensus of "Hold" and a price target of $20.00. Institutional investors are actively trading the stock.

Market Beat·
US
TLRY
+44.13%
Market Beat·
US
TLRY
+44.13%

TSX Reverses Early Session Gains

The S&P/TSX Composite fell 0.3% below 31,700 due to tech valuation concerns, with Broadcom's AI chip sales outlook disappointing. Celestica led declines, while mining equities faded. Cannabis stocks soared on reports of US federal easing, with Tilray up 40% and Canopy Growth up 50%. The week saw central bank decisions, with BoC steady and US Fed cutting rates, lifting risk appetite.

Trading Economics·
US
TLRY
+44.13%
US
CGC
+53.98%
Trading Economics·
US
TLRY
+44.13%
US
CGC
+53.98%
© 2025 Longbridge｜Disclaimer